Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Psychopharmacology (Oxford, England)|October 3, 2024
Mechanisms of psilocybin on the treatment of posttraumatic stress disorderCharles Choi, Danica E Johnson, David Chen-Li, et al.
Expert Opinion on Pharmacotherapy|March 22, 2023
An update on potential pharmacotherapies for cognitive impairment in bipolar disorderDanica E Johnson, Roger S McIntyre, Rodrigo B Mansur, et al.
Psychiatry Research|April 9, 2026
Psychedelics as a potential treatment for borderline personality disorder: A narrative reviewErin Artna, Guneet Sandhu, Noah Chisamore, et al.
Journal of Affective Disorders|December 31, 2025
A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: Do the molecular and synaptic plasticity effects inform dosing intervals?Gia Han Le, Sabrina Wong, Danica E Johnson, et al.
Therapeutic Advances in Psychopharmacology|September 29, 2023
Ketamine for bipolar depression: an updated systematic reviewFarhan Fancy, Sipan Haikazian, Danica E Johnson, et al.
Psychiatry Research|October 16, 2023
Psilocybin-assisted therapy for depression: A systematic review and meta-analysisSipan Haikazian, David C J Chen-Li, Danica E Johnson, et al.
Clinical Pharmacology and Therapeutics|May 28, 2026
The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of DepressionGia Han Le, Sabrina Wong, Danica E Johnson, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 25, 2025
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étudeNoah Chisamore, Erica S Kaczmarek, Zoe Doyle, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2024
Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depressionDanica E Johnson, Nelson B Rodrigues, Sydney Weisz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 24, 2025
Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialDanica E Johnson, Shakila Meshkat, Erica S Kaczmarek, et al.
Pageof 2